List of bibliographic references
Number of relevant bibliographic references: 15.
| Ident. | Authors (with country if any) | Title |
|---|
| 000039 (2015) |
Dianbo Qu ; Ali Hage ; Katie Don-Carolis ; En Huang ; Alvin Joselin ; Farzaneh Safarpour ; Paul C. Marcogliese ; Maxime W. C. Rousseaux ; Sarah J. Hewitt ; Tianwen Huang ; Doo-Soon Im ; Steve Callaghan ; Danielle Dewar-Darch [Canada] ; Daniel Figeys [Canada] ; Ruth S. Slack ; David S. Park | BAG2 Gene-mediated Regulation of PINK1 Protein Is Critical for Mitochondrial Translocation of PARKIN and Neuronal Survival* |
| 000318 (2003) |
Patrice D. Smith [Canada] ; Stephen J. Crocker [Canada] ; Vernice Jackson-Lewis ; Kelly L. Jordan-Sciutto [États-Unis] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Michael J. O'Hare [Canada] ; Steven Callaghan [Canada] ; Ruth S. Slack [Canada] ; Serge Przedborski [États-Unis] ; Hymie Anisman [Canada] ; David S. Park [Canada] | Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease |
| 000319 (2005) |
Raymond H. Kim [Canada] ; Patrice D. Smith [Canada] ; Hossein Aleyasin [Canada] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Scott Pownall [Canada] ; Andrew Wakeham [Canada] ; Annick J. You-Ten [Canada] ; Suneil K. Kalia [Canada] ; Patrick Horne [Canada] ; David Westaway [Canada] ; Andres M. Lozano [Canada] ; Hymie Anisman [Canada] ; David S. Park [Canada] ; Tak W. Mak [Canada] | Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress |
| 000421 (2010) |
Subhas C. Biswas [États-Unis] ; Yi Zhang [Canada] ; Grace Iyirhiaro [Canada] ; Ryan T. Willett [États-Unis] ; Yasmilde Rodriguez Gonzalez [Canada] ; Sean P. Cregan ; Ruth S. Slack [Canada] ; David S. Park [Canada] ; Lloyd A. Greene [États-Unis] | SERTAD1 PLAYS AN ESSENTIAL ROLE IN DEVELOPMENTAL AND PATHOLOGICAL NEURON DEATH |
| 000559 (2011) |
Arman Lira ; Jerzy Kulczycki ; Ruth Slack ; Hymie Anisman ; David S. Park | Involvement of the Fcγ Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss* |
| 000565 (2012) |
M. Emdadul Haque ; Matthew P. Mount ; Farzaneh Safarpour ; Elizabeth Abdel-Messih ; Steve Callaghan ; Chantal Mazerolle ; Tohru Kitada ; Ruth S. Slack ; Valerie Wallace ; Jie Shen ; Hymie Anisman ; David S. Park | Inactivation of Pink1 Gene in Vivo Sensitizes Dopamine-producing Neurons to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Can Be Rescued by Autosomal Recessive Parkinson Disease Genes, Parkin or DJ-1 |
| 000572 (2013) |
Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. Park | Perturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)* |
| 000655 (2010) |
Hossein Aleyasin [Canada] ; Maxime W. C. Rousseaux [Canada] ; Paul C. Marcogliese [Canada] ; Sarah J. Hewitt [Canada] ; Isabella Irrcher [Canada] ; Alvin P. Joselin [Canada] ; Mohammad Parsanejad [Canada] ; Raymond H. Kim [Canada] ; Patrizia Rizzu [Pays-Bas] ; Steve M. Callaghan [Canada] ; Ruth S. Slack [Canada] ; Tak W. Mak [Canada] ; David S. Park [Canada, Corée du Sud] | DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway |
| 000660 (2007) |
Hossein Aleyasin [Canada] ; Maxime W. C. Rousseaux [Canada] ; Maryam Phillips [Canada] ; Raymond H. Kim [Canada] ; Ross J. Bland [États-Unis] ; Steve Callaghan [Canada] ; Ruth S. Slack [Canada] ; Matthew J. During [États-Unis] ; Tak W. Mak [Canada] ; David S. Park [Canada] | The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage |
| 000661 (2008) |
M. Emdadul Haque [Canada] ; Kelly J. Thomas [États-Unis] ; Cheryl D'Souza [Canada] ; Steve Callaghan [Canada] ; Tohru Kitada [États-Unis] ; Ruth S. Slack [Canada] ; Paul Fraser [Canada] ; Mark R. Cookson [États-Unis] ; Anurag Tandon [Canada] ; David S. Park [Canada] | Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP |
| 000663 (2012) |
Maxime W. C. Rousseaux ; Paul C. Marcogliese ; Dianbo Qu ; Sarah J. Hewitt ; Sarah Seang ; Raymond H. Kim ; Ruth S. Slack ; Michael G. Schlossmacher ; Diane C. Lagace ; Tak W. Mak ; David S. Park [Corée du Sud] | Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease |
| 000907 (2011) |
Mansoureh Hakimi [Canada] ; Thirumahal Selvanantham [Canada] ; Erika Swinton [Canada] ; Ruth F. Padmore [Canada] ; Youren Tong [États-Unis] ; Ghassan Kabbach [Canada] ; Katerina Venderova [Canada] ; Stephen E. Girardin [Canada] ; Dennis E. Bulman [Canada] ; Clemens R. Scherzer [États-Unis] ; Matthew J. Lavoie [États-Unis] ; Denis Gris [États-Unis] ; David S. Park [Canada] ; Jonathan B. Angel [Canada] ; Jie Shen [États-Unis] ; Dana J. Philpott [Canada] ; Michael G. Schlossmacher [Canada] | Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures |
| 000B10 (2014) |
Gonzalo Sanchez [Canada] ; Rafael K. Varaschin [Canada] ; Hansruedi Büeler [République populaire de Chine] ; Paul C. Marcogliese [Canada] ; David S. Park [Canada] ; Louis-Eric Trudeau [Canada] | Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice |
| 000B15 (2014) |
Mohammad Parsanejad [Canada] ; Noam Bourquard [États-Unis] ; Dianbo Qu [Canada] ; Yi Zhang [Canada] ; En Huang [Canada] ; Maxime W. C. Rousseaux [Canada, États-Unis] ; Hossein Aleyasin [Canada, États-Unis] ; Isabella Irrcher [Canada] ; Steve Callaghan [Canada] ; Dominique C. Vaillant [Canada] ; Raymond H. Kim [Canada] ; Ruth S. Slack [Canada] ; Tak W. Mak [Canada] ; Srinivasa T. Reddy [États-Unis] ; Daniel Figeys [Canada] ; David S. Park [Canada, Corée du Sud] | DJ-1 Interacts with and Regulates Paraoxonase-2, an Enzyme Critical for Neuronal Survival in Response to Oxidative Stress |
| 000B80 (2012) |
Katerina Venderova [États-Unis] ; David S. Park [Canada] | Programmed Cell Death in Parkinson's Disease |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Pmc/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/Author.i -k "David S. Park"
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/Author.i \
-Sk "David S. Park" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Pmc
|étape= Curation
|type= indexItem
|index= Author.i
|clé= David S. Park
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
